Surgery is the cornerstone treatment for limited stage non-small cell lung cancer and car-cinoid tumours, and may be considered for some cases of small-cell lung cancer. Before considering a patient for surgical resection, two points must be taken into account: the resectability – the surgeon’s ability for taking out all the cancer tissue – and the operability – the patient’s ability to tolerate the surgical intervention with adequate recovery and quality of life. Resectability depends on disease extent, while operability’s consequences are measured by the operative risk (mortality and morbidity), taking into account patient’s characteristics: comorbidities, cardiac and respiratory function, and general condition. This article will assess operability, with a particular attention to the cardiorespiratory work-up and decisional algorithms.
手术是治疗局限期非小细胞肺癌和类癌的基础方法，某些小细胞肺癌病例也可考虑手术治疗。在考虑对患者进行手术切除之前，必须考虑两点：可切除性--外科医生切除所有癌组织的能力；可操作性--患者能否耐受手术治疗，并获得足够的康复和生活质量。可切除性取决于疾病的程度，而可操作性的后果则由手术风险（死亡率和发病率）来衡量，同时考虑到患者的特征：合并症、心脏和呼吸功能以及全身状况。本文将对可手术性进行评估，尤其关注心肺功能检查和决策算法。由 Elsevier Masson SAS 出版。保留所有权利。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
